Morgan Stanley Initiates Coverage On Compass Pathways with Overweight Rating, Announces Price Target of $30
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Vikram Purohit initiates coverage on Compass Pathways (CMPS) with an Overweight rating and a price target of $30.

April 01, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley initiated coverage on Compass Pathways with an Overweight rating and a price target of $30.
The initiation of coverage by a major financial institution like Morgan Stanley, especially with an Overweight rating and a specific price target, is typically seen as a positive signal to the market. This can lead to increased investor interest and potentially drive the stock price up in the short term, as it reflects confidence in the company's future performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100